thebench.bio

Manufacturing Daily Summary

Manufacturing Daily Summary: What Happened on October 5, 2026

Bayer plans $2.2 billion Ohio manufacturing site

The facility is scheduled to start production in stages in 2031 and 2034. Biogen is also spending on its North Carolina expansion.

  • Updated
  • Read from 2 articles, 2 publications

Today in brief

Bayer plans a $2.2 billion pharmaceutical plant at New Albany International Business Park in Ohio.1 The company estimates construction will generate nearly 1,500 jobs, with about 600 roles at the operating site.1

Bayer plans Ohio site with production starting in 2031

Bayer plans to build a $2.2 billion pharmaceutical manufacturing facility at New Albany International Business Park.1 The modular site would make drug substances, the active ingredients in medicines, and finished drug products, using automated and digital systems.1

Bayer plans to open the first drug-substance module in 2031 and a drug-product unit in 2034.1 The facility is intended to support medicines in cardiovascular, cancer, and kidney care.1 Construction is expected to create nearly 1,500 jobs. The operating site is projected to support about 600 roles.1

Also worth knowing

  • Biogen executive Nicole Murphy said the company had executed about $200 million year-to-date in 2026 toward its previously announced $2 billion Research Triangle Park expansion, including an antisense oligonucleotide purification facility and added synthesis capacity.2

Also published